Some studies suggest that T4 monotherapy doesn’t normalize BMR; others say it’s fine. The jury may be out on this, but it’s nonetheless fascinating to look at the strength (or lack thereof) of the original studies using BMR to guide treatment.
In a new clinical trial, study participants preferred desiccated thyroid and T4/T3 combination therapy over T4 alone, but is there more to this than the conclusion?
You can call it Alternative Medicine, CAM, Naturopathy, Integrative Medicine, or Functional Medicine – doesn’t matter – a duck is still a duck. Come be a voyeur as a reader shares her real-life experience with a FM doc.
Which sounds better to you: taking a physiologic dose of T3, or a heroic bolus that acts like an illicit stimulant? If you get your care from alt med, chances are you’ll be slammed with the latter.
In a special guest post, HD’s daughter gives readers a peek at what it’s like to live with an Endocrinologist. Hint: sugar is a four-letter word in the house.
Living during this time of the all-consuming coronavirus is ridiculously stressful. If you had the choice to merely survive this ordeal or actually thrive, which would you pick? Yeah, me too.
Can you believe I’ve been doing this for three years now? Fortunately, I’m particularly susceptible to inertia, which has made it fairly easy to continue doing what I launched back in March 2017. Regular readers will remember the victory lap I took in March 2018 after achieving all the goals I set out in my original mission statement. My two-year update in 2019 was not quite as dramatic, but there was some meaningful stuff in there, including the cliff-hanger about a talk I was asked to give to a national audience of Endocrinologists – so let’s kick off the year-in-review with that!
In assessing whether there is value in monitoring T3 levels and restoring them to normal in hypothyroidism, I think it helps to return to first principles. And no, “more T3 is better” is not a first principle.
In this next post in the T3 Controversies series, we cover whether T3 therapy must be used to account for tissues that can’t make their own T3.
In this first post of my “T3 Controversies” series, I address the claim that there are acquired forms of tissue resistance to thyroid hormone, which can be treated with high-dose T3 therapy.